Eric Van Der Putten Email & Phone Number
@modrapharmaceuticals.com
1 phone found area 130
LinkedIn matched
Who is Eric Van Der Putten? Overview
A concise factual answer block for searchers comparing this professional profile.
Eric Van Der Putten is listed as CEO Modra Pharmaceuticals | Partner at Aglaia Oncology Funds at Modra Pharmaceuticals, based in Amsterdam, North Holland, Netherlands. AeroLeads shows a work email signal at modrapharmaceuticals.com, phone signal with area code 130, and a matched LinkedIn profile for Eric Van Der Putten.
Eric Van Der Putten previously worked as Chief Executive Officer at Modra Pharmaceuticals and Director at Modra Pharmaceuticals. Eric Van Der Putten holds Bsc, Pathology And Histology (1979-1981) - Immunology (1983-1985) from Hbo-University Amsterdam.
Email format at Modra Pharmaceuticals
This section adds company-level context without repeating Eric Van Der Putten's masked contact details.
AeroLeads found 1 current-domain work email signal for Eric Van Der Putten. Compare company email patterns before reaching out.
About Eric Van Der Putten
Senior clinical development expert with more than 25 years of experience leading Phase I - III studies in oncology. Demonstrated experience in start-up, established and transition phase programs including managing vendor oversight, budgeting/forecasting, and client relationship building and maintenance as well as ensuring compliance with federal regulations (FDA, ANVISA, EMA). Experienced in all aspects of data delivery and study start-ups for multi-site trials with up to 300 employees. Significant experience in developing strategic direction and establishing effective drug development programs.
Listed skills include Clinical Development, Oncology, Cro, Clinical Trials, and 15 others.
Eric Van Der Putten's current company
Company context helps verify the profile and gives searchers a useful next step.
Eric Van Der Putten work experience
A career timeline built from the work history available for this profile.
Director
Modra Pharmaceuticals is a clinical stage company that develops new treatment paradigms by enabling oral bioavailability of existing anticancer drugs, “the iv to oral switch”, to improve cancer therapy and supportive care. Modra Pharmaceuticals has several products in preclinical and clinical development including oral formulations of docetaxel and.
Board Member
CurrentMIMETAS develops predictive Organ-on-a-Chip cell culture models for better, more reliable and tailored medicines.
Partner
CurrentAglaia invests in companies offering groundbreaking therapies for the prevention and cure of cancer. Aglaia differs from other funds in that it focuses exclusively on oncology, as well as by getting involved at an early stage of technological development and through its hands-on management and efficient allocation of capital. Through this strategy, the.
Consultant
Expert advice on oncology drug development for pharma and biotech companies.
Co-Founder
Professional CRO services for oncology clinical trials in all phases (I-IV) of clinical development, from writing development plans and protocols to site selection, investigator management, assurance of patient accrual, site monitoring, data management, biostatistics and report writing.
Chief Operating Officer, Chief Executive Officer
Vice President Oncology Europe
Chief Executive Officer
Director Project Management
Director Product & Business Development
Manager European Business Development
Senior Project Supervisor
Head Trial Department
Eric Van Der Putten education
Bsc, Pathology And Histology (1979-1981) - Immunology (1983-1985)
Strategy In Pharmaceutical Industry, Post-Graduate Course
Health Economics For Non-Health-Economists
Atheneum B
Frequently asked questions about Eric Van Der Putten
Quick answers generated from the profile data available on this page.
What company does Eric Van Der Putten work for?
Eric Van Der Putten works for Modra Pharmaceuticals.
What is Eric Van Der Putten's role at Modra Pharmaceuticals?
Eric Van Der Putten is listed as CEO Modra Pharmaceuticals | Partner at Aglaia Oncology Funds at Modra Pharmaceuticals.
What is Eric Van Der Putten's email address?
AeroLeads has found 1 work email signal at @modrapharmaceuticals.com for Eric Van Der Putten at Modra Pharmaceuticals.
What is Eric Van Der Putten's phone number?
AeroLeads has found 1 phone signal(s) with area code 130 for Eric Van Der Putten at Modra Pharmaceuticals.
Where is Eric Van Der Putten based?
Eric Van Der Putten is based in Amsterdam, North Holland, Netherlands while working with Modra Pharmaceuticals.
What companies has Eric Van Der Putten worked for?
Eric Van Der Putten has worked for Modra Pharmaceuticals, Mimetas, Aglaia Oncology Funds, Evdp Consultancy, and Sms-Oncology.
How can I contact Eric Van Der Putten?
You can use AeroLeads to view verified contact signals for Eric Van Der Putten at Modra Pharmaceuticals, including work email, phone, and LinkedIn data when available.
What schools did Eric Van Der Putten attend?
Eric Van Der Putten holds Bsc, Pathology And Histology (1979-1981) - Immunology (1983-1985) from Hbo-University Amsterdam.
What skills is Eric Van Der Putten known for?
Eric Van Der Putten is listed with skills including Clinical Development, Oncology, Cro, Clinical Trials, Drug Development, Pharmaceutical Industry, Cancer, and Biotechnology.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial